Document:

Exhibit 10.2

 

THIS ASSET PURCHASE
AGREEMENT (the “Agreement”) is made and entered into as of October 25, 2017 among GENEXOSOME TECHNOLOGIES INC.,
a Nevada corporation (“Buyer”) and Yu Zhou (the “Seller”).

 

WHEREAS, the
Seller is engaged in the business of researching, developing and commercializing exosome technologies (the “Business”);
and

 

WHEREAS, the
Seller desires to sell, and the Buyer desires to purchase and acquire all of the Assets (as hereinafter defined) including, without
limitation, all intellectual property and contractual rights and the other assets either designated in this Agreement and/or utilized
in the Seller’s Business;

 

NOW, THEREFORE,
in consideration of the mutual benefits to be derived from this Agreement and the representations, warranties, covenants, agreements,
conditions and promises contained herein and therein, the parties hereto hereby agree as follows:

 

ARTICLE 1.  

PURCHASE AND SALE OF ASSETS 

 

1.1. PURCHASE AND SALE
OF ASSETS. In accordance with the provisions of this Agreement, the Seller hereby sells, transfers, assigns and delivers free from
all liens, charges and encumbrances to the Buyer, and the Buyer hereby purchases, acquires and accepts from the Seller, the right,
title and interest in and to all of the properties and assets of the Seller (the “Assets”) that are used and/or necessary
for the Business, including, but not limited to, the assets set forth on Schedule 1.1, and the following assets:

 

(a)                
All industrial and intellectual property rights, including, without limitation, those certain
patents set forth on Schedule 1.1(a), all other patents not specifically set forth herein, patent applications, patent rights,
trademarks, trademark applications, trade names, service marks, service mark applications, copyrights, copyright registrations,
copyright applications, franchises, licenses, databases, “URL’s” and Internet domain names and applications therefor
(and all interest therein), computer programs and other computer software, user interfaces, know-how, trade secrets, customer lists,
proprietary technology, processes and formulae, source code, object code, algorithms, architecture, structure, display screens,
layouts, development tools, instructions, templates, marketing materials, inventions, trade dress, logos and designs and all documentation
and media constituting, describing or relating to the foregoing (“Intellectual Property Rights”); 

 

(b)                
all equipment and tangible personal property owned or leased by the Seller);

 

(c)                
the unused brochures, literature, advertising, catalogues, photographs, display materials,
media materials, packaging materials and other similar items which have been produced by or for the Seller;

 

(d)                
the photographs, display materials, media materials, packaging materials, business plans,
presentations, and other similar items which have been produced by or for the Seller;

 

(e)                
the goodwill of the Seller in connection with the Business and the exclusive right to represent
itself as carrying on the Business in succession to Seller; and

 

(f)                 
all other assets (i.e., other than as described above and properties of every nature whatsoever,
without limitation, whether tangible and intangible, and wherever located of the Seller.

 

1.2. EXCLUDED LIABILITIES.

 

(a)           It
is expressly agreed and understood that the Buyer shall not assume any liabilities (collectively, the liabilities not being assumed
by the Buyer are referred to herein as “Excluded Liabilities”). All responsibility with respect to all liabilities
of the Seller including, but not limited to, the Excluded Liabilities, shall remain with the Seller.

 

     

     

    

 

(b)       The
Buyer shall not assume or be bound by any obligations or liabilities of the Seller or any affiliate of the Seller of any kind or
nature, known, unknown, accrued, absolute, contingent or otherwise, whether now existing or hereafter arising.

 

(c)       The
Seller shall be solely (as between the Seller and the Buyer) responsible for and pay any and all debts, losses, damages, obligations,
liens, assessments, judgments, fines, disposal and other costs and expenses, liabilities and claims, including, without limitation,
interest, penalties and fees of counsel and experts, as the same are incurred, of every kind or nature whatsoever made by or owed
to any person.

 

1.3. PURCHASE PRICE.

 

(a) PAYMENT
OF CONSIDERATION. The aggregate purchase price payable for the Assets consists of:

 

(i) an aggregate of $876,087
in cash (the “Cash Consideration”);

 

(ii) 500,000 shares of common
stock, $0.0001 par value per share, of Avalon GloboCare Corp. (“Avalon”) held by the Buyer (the “Avalon Stock”);

 

(iii) 400 shares of common stock,
$0.0001 par value per share, of the Buyer (together with the Avalon Stock, the “Stock Consideration”).

 

(b) TAXES.
The Seller shall pay any and all municipal, county, state and federal sales and documentary transfer taxes, impositions, liens,
leases, assessments and similar charges if any, incurred by the Buyer or the Seller in connection with the transaction contemplated
by this Agreement. Each party shall in a timely manner sign and swear to any return, certificate, questionnaire or affidavit as
to matters within its knowledge required in connection with the payment of any such tax.

 

1.4. CLOSING. The closing
of the transactions contemplated hereunder (the “Closing”) will take place on October 25, 2017 (the “Closing Date”),
unless another date is agreed to in writing by the parties. The Closing shall take place at the offices of Avalon, 83 South Street,
Suite 101, Freehold, New Jersey 07728, unless another place is agreed to in writing by the parties. As of the Closing Date, all
of the Assets will be transferred to the Buyer. Within thirty (30) days of the Closing, the Cash Consideration will be delivered
by wire transfer in accordance with the instructions provided by the Seller. Within thirty (30) days of the Closing, the Stock
Consideration will be issued and delivered to the Seller in accordance with the instructions provided by the Seller.

 

ARTICLE 2.  

REPRESENTATIONS AND WARRANTIES 

 

As used with respect
to the Seller or the Buyer, as the case may be, the term “Material Adverse Effect” or “Material Adverse Change”
means (i) any change, event, inaccuracy, violation, circumstance or effect, individually or in the aggregate, that has or
is reasonably likely to have a material adverse effect on the business, assets (including intangible assets), operations, results
of operations, properties or financial condition of the party and its subsidiaries taken as a whole, other than changes or effects
(A) caused by changes in general economic or securities markets conditions, (B) that affect the business in which such
party and its subsidiaries operate in general and that do not have a materially disproportionate effect on such party and its subsidiaries
or (C) resulting from the announcement or proposed consummation of this Agreement and the transactions contemplated hereby
(including any security holder class action litigation arising from allegations of a breach of fiduciary duty relating to this
Agreement).

 

2.1. REPRESENTATIONS
AND WARRANTIES OF THE SELLER. The Seller represents and warrants to the Buyer as set forth below.

 

(a) QUALIFICATION
AND POWER. The Seller has all requisite power and authority to (A) own, lease and operate their properties and assets and to carry
on business as now being conducted and as proposed to be conducted, (B) to enter into this Agreement, (C) to perform the obligations
hereunder and thereunder, and (D) to consummate the transactions contemplated hereby and thereby.

 

    2 

     

    

 

(b) ABSENCE
OF UNDISCLOSED LIABILITIES. As of the Closing Date (i) the Seller had no liability or obligation of any nature (whether known or
unknown, matured or unmatured, fixed or contingent, secured or unsecured, accrued, absolute or otherwise (“Liability”))
which was not provided for or disclosed as of the Closing Date, and (ii) all liability reserves established by the Seller and set
forth thereon were adequate for all such Liabilities at the respective dates thereof.

 

(c) INTELLECTUAL PROPERTY.

 

(i) The Seller has good and valid
title to, and owns free and clear of all encumbrances, has the exclusive right to use, sell, transfer, market, manufacture, license
(or sublicense), deliver and dispose of, and has the right to bring actions for the infringement of, all Intellectual Property
Rights (collectively, the “Seller Rights”).

 

(ii) The execution, delivery and
performance of this Agreement and the consummation of the transactions contemplated hereby will not breach, violate or conflict
with any instrument or agreement governing any Seller Rights, will not cause the forfeiture or termination or give rise to a right
of forfeiture or termination of any Seller Right or in any way impair the right of the Seller or the Buyer to use, sell, market,
manufacture, license (or sublicense), deliver, dispose of, or to bring any action for the infringement of, any Seller Right or
portion thereof.

 

(iii) There are no royalties, honoraria,
fees or other payments payable by the Seller to any person by reason of the ownership, use, license (or sublicense), delivery,
sale, or disposition of the Seller Rights, other than sales commissions paid in the ordinary course of business.

 

(iv) Neither the manufacture, marketing,
license (or sublicense), sale, delivery, or use of any product or service currently or proposed to be licensed, sold, manufactured,
marketed, delivered or used by the Seller or currently under development by the Seller, violates any license (or sublicense) or
agreement of the Seller with any third party or, to the best knowledge of the Seller, infringes any common law or statutory rights
of any other party, including, without limitation, rights relating to defamation, contractual rights, Intellectual Property Rights
and rights of privacy or publicity; nor, to the best knowledge of the Seller, is any third party infringing upon, or violating
any license (or sublicense), delivery or agreement with the Seller relating to any Seller Right; and there is no pending or, to
the best knowledge of the Seller, threatened claim or litigation contesting the validity, ownership or right to use, manufacture,
market, sell, license (or sublicense), deliver or dispose of any Seller Right, nor has the Seller received any notice asserting
that any Seller Right or the proposed use, manufacture, marketing, sale, license (or sublicense), delivery or disposition thereof
conflicts or will conflict with the rights of any other party.

 

(v) Other than professionals bound
by ethical obligations of their profession not to disclose such information, all current and past officers, employees and consultants
of or to the Seller have executed and delivered to and in favor of the Seller an agreement regarding the protection of confidential
and proprietary information and the assignment to the Seller of all Intellectual Property Rights arising from the services performed
for the Seller by such persons. The Seller has taken and will continue through the Closing Date to take all steps reasonably necessary,
appropriate or desirable to safeguard and maintain the secrecy and confidentiality of, and its proprietary rights in, all Seller
Rights.

 

(vi) All works that were created,
prepared or delivered by consultants, independent contractors or other third parties for or on behalf of Seller (including any
materials and elements created, prepared or delivered by such parties in connection therewith) (A) are and shall constitute “works
made for hire” specially ordered or commissioned by the Seller within the meaning of United States’ copyright law, or (B)
all right, title and interest therein (including any materials and elements created, prepared or delivered by such parties in connection
therewith) have been assigned to the Seller.

 

    3 

     

    

 

(vii) No person has any marketing
rights to any of the Intellectual Property Rights of the Seller (excluding Intellectual Property Rights licensed to the Seller
by third parties).

 

(viii) Schedule 1.1(a) of
the Seller Disclosure Schedule contains a true and complete list of all (A) of the Seller’s patents, patent applications, patent
design ideas, trademarks, trademark applications, trade names, service marks, service mark applications, copyrights, copyright
registrations and copyright applications and Internet domain names and applications therefor and (B) other filings and formal actions
made or taken pursuant to Federal, state, local and foreign laws by the Seller to perfect or protect its interest therein.

 

(d) LITIGATION, ETC.
There are no (i) actions, suits, claims, investigations or legal or administrative or arbitration proceedings pending, or to the
best knowledge of the Seller, threatened against the Seller, whether at law or in equity, or before or by any Federal, state, local,
municipal, foreign or other governmental court, department, commission, board, bureau, agency or instrumentality (“Governmental
Authority”), (ii) judgments, decrees, injunctions or orders of any Governmental Authority or arbitrator against the Seller
or (iii) disputes with customers or vendors.

 

(e) KNOWLEDGE DEFINITION.
As used in this Article 2, the term “best knowledge” and like phrases shall mean and include the knowledge, after due
inquiry.

 

2.2. REPRESENTATIONS
AND WARRANTIES OF THE BUYER.

 

The Buyer represents
and warrants to the Seller as set forth below.

 

(a) ORGANIZATION;
GOOD STANDING; QUALIFICATION AND POWER. The Buyer (i) is a corporation duly organized, validly existing and in good standing under
the laws of the State of Nevada, and (ii) has all requisite corporate power and authority to own, lease and operate its properties
and assets and to carry on its business as now being conducted, to enter into this Agreement, to perform its obligations hereunder
and thereunder and to consummate the transactions contemplated hereby and thereby. The Buyer has delivered to the Seller true and
complete copies of the Charter and by-laws of the Buyer. The Buyer is qualified to do business and is in good standing in each
in jurisdiction in which the nature of its business requires it to be so qualified except where the failure to so qualify would
not have a Material Adverse Effect.

 

(b) CAPITAL STOCK.
The Buyer has provided to Seller a true and complete description of the authorized and outstanding shares of capital stock of the
Buyer as of the Closing Date

 

(c) AUTHORITY. The
execution, delivery and performance by the Buyer of this and the consummation of the transactions contemplated hereby and thereby
have been duly authorized by all necessary corporate action on the part of the Buyer. This Agreement is a valid and binding obligation
of the Buyer, enforceable against the Buyer in accordance with their respective terms, except as such enforceability may be limited
by equitable principles and by applicable bankruptcy, insolvency, reorganization, arrangement, moratorium and similar laws relating
to or affecting the rights of creditors, generally.

 

ARTICLE 3. 

CONDITIONS PRECEDENT 

 

3.1. CONDITIONS TO
EACH PARTY’S OBLIGATIONS. The obligations of each party hereto to perform this Agreement is subject to the satisfaction of the
following conditions unless waived (to the extent such conditions can be waived) by all parties hereto:

 

(a) APPROVALS.
The Buyer and the Seller shall have timely obtained from each Governmental Authority all approvals, waivers and consents, if any,
necessary for consummation of the transactions contemplated hereby, including such approvals, waivers and consents as may be required
under the Securities Act and under state securities laws.

 

    4 

     

    

 

(c) LEGAL
ACTION. No temporary restraining order, preliminary injunction or permanent injunction or other order preventing the consummation
of the transactions contemplated hereunder shall have been issued by any Federal or state court or other Governmental Authority
and remain in effect.

 

(d) LEGISLATION.
No Federal, state, local or foreign statute, rule or regulation shall have been enacted which prohibits, restricts or delays the
consummation of the transactions contemplated by this Agreement or any of the conditions to the consummation of such transactions.

 

3.2. CONDITIONS TO
OBLIGATIONS OF THE BUYER. The obligations of the Buyer to perform this Agreement is subject to the satisfaction of the following
conditions unless waived (to the extent such conditions can be waived) by the Buyer at the Closing:

 

(a) REPRESENTATIONS
AND WARRANTIES OF THE SELLER. The representations and warranties of the Seller set forth in Section 2.1 hereof shall be true and
correct as of the Closing Date (except to the extent any such representation or warranty expressly speaks as of an earlier date,
which representations and warranties shall be true and correct as of such date in the same manner as specified above).

 

(b) PERFORMANCE
OF OBLIGATIONS OF THE SELLER. The Seller shall have performed in all material respects the obligations required to be performed
by each of them under this Agreement prior to or as of the Closing Date.

 

(c) CONSENTS
AND APPROVALS. Duly executed copies of all consents and approvals contemplated by this Agreement, in form and substance satisfactory
to the Buyer, shall have been delivered by the Seller.

 

(d) GOVERNMENT
CONSENTS, AUTHORIZATIONS, ETC. Copies of all consents, authorizations, orders or approvals of, and filings or registrations with,
any Governmental Authority which are required for or in connection with the execution and delivery by the Seller of this Agreement
and the consummation by the Seller and each of the Shareholders of the transactions contemplated hereby, shall have been delivered
by the Seller.

 

3.3. CONDITIONS TO
OBLIGATIONS OF THE SELLER. The obligations of the Seller to perform this Agreement to which they are a party are subject to the
satisfaction of the following conditions unless waived (to the extent such conditions can be waived) by the Seller:

 

(a) REPRESENTATIONS
AND WARRANTIES OF THE BUYER. The representations and warranties of the Buyer set forth in Section 2.2 hereof shall be true and
correct as of the Closing Date as though made on and as of the Closing Date (except to the extent any such representation or warranty
expressly speaks as of an earlier date, which representations and warranties shall be true and correct as of such date in the same
manner as specified above), and the Seller shall have received a certificate signed on behalf of the Buyer by the Chief Executive
Officer of the Buyer to such effect.

 

(b) PERFORMANCE
OF OBLIGATIONS OF THE BUYER. The Buyer shall have performed in all material respects its obligations required to be performed by
it under this Agreement prior to or as of the Closing Date.

 

(c) GOVERNMENT
CONSENTS, AUTHORIZATIONS, ETC. Copies of all consents, authorizations, orders or approvals of, and filings or registrations with,
any Governmental Authority which are required for or in connection with the execution and delivery by the Buyer of this Agreement
and the consummation by the Buyer of the transactions contemplated hereby or thereby, shall have been delivered by the Buyer.

 

(d) PURCHASE
PRICE. The delivery of the Consideration in the manner and otherwise in accordance with Article 1 hereof, shall have been made
by the Buyer.

 

    5 

     

    

 

ARTICLE 4. 

ADDITIONAL AGREEMENTS 

 

4.1. RESTRICTIONS ON
TRANSFER.

 

(a) The Stock
Consideration to be issued to the Seller at the Closing Date shall not be sold, transferred, assigned, pledged, encumbered or otherwise
disposed of (each, a “Transfer”) except upon the conditions specified in this Section 4.1, which conditions are intended
to insure compliance with the provisions of the Securities Act. The Seller shall observe and comply with the Securities Act and
the rules and regulations promulgated by the SEC thereunder as now in effect or hereafter enacted or promulgated, and as from time
to time amended, in connection with any Transfer of the Stock Consideration beneficially owned by the Seller.

 

(b) Each
certificate representing the Stock Consideration issued to the Seller and each certificate for such securities issued to subsequent
transferees of any such certificate shall (unless otherwise permitted by the provisions of Section hereof) be stamped or otherwise
imprinted with a legend in substantially the following form:

 

“THE SECURITIES REPRESENTED
BY THIS CERTIFICATE HAVE BEEN ACQUIRED FOR INVESTMENT AND HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED,
OR ANY APPLICABLE STATE SECURITIES OR “BLUE-SKY” LAWS. THESE SECURITIES MAY NOT BE SOLD, TRANSFERRED, ASSIGNED, PLEDGED,
ENCUMBERED OR OTHERWISE DISPOSED OF IN THE ABSENCE OF SUCH REGISTRATION OR AN EXEMPTION THEREFROM.”

 

4.2. CONFIDENTIALITY.
Each party hereto agrees that any information obtained by such party (the “Receiving Party”) pursuant to or in connection
with this Agreement and the transactions contemplated hereby and thereby which may be proprietary or otherwise confidential to
any other party hereto (the “Disclosing Party”) will not be disclosed by the Receiving Party without the prior written
consent of the Disclosing Party. Each party further acknowledges and understands that any information obtained which may be considered
“inside” non-public information will not be utilized by such party in connection with purchases and/or sales of the Avalon’s
shares of common stock except in compliance with applicable state and federal anti-fraud statutes.

 

4.3        POST
CLOSING; ASSIGNMENT. Following the Closing, each of the Seller’s shall take all appropriate actions and execute all required
paperwork to assign, transfer and convey all Assets, including, but not limited to, all Intellectual Property Rights, to the Buyer.

 

ARTICLE 5. 

INDEMNIFICATION 

 

5.1. DEFINITIONS. As used in this Agreement,
the following terms shall have the following meanings:

 

(a) “AFFILIATE”
as to any person means any entity, directly or indirectly, through one or more intermediaries, controlling, controlled by or under
common control with such person.

 

(b) “EVENT
OF INDEMNIFICATION” shall mean the following:

 

(i) the untruth,
inaccuracy or breach of any representation or warranty of the Seller (including the fact and circumstances underlying such untruth,
inaccuracy or breach) contained in Section 2.1 of this Agreement, any Exhibit or Schedule hereto or any other document delivered
in connection herewith or therewith (without giving effect to any “Material Adverse Effect” or other materiality qualification
or any similar qualification contained or incorporated directly or indirectly in such representation or warranty);

 

    6 

     

    

 

(ii) intentionally
left blank;

 

(iii) the breach
of any agreement or covenant of the Seller contained in this Agreement , any Exhibit hereto or any other document delivered in
connection herewith or therewith;

 

(iv) the untruth,
inaccuracy or breach of any representation or warranty of the Buyer (including the fact and circumstances underlying such untruth,
inaccuracy or breach) contained in Section 2.2 of this Agreement, any Exhibit or Schedule hereto or any other document delivered
in connection herewith (without giving effect to any “Material Adverse Effect” or other materiality qualification or
any similar qualification contained or incorporated directly or indirectly in such representation or warranty) or

 

(v) the breach
of any agreement or covenant of the Buyer contained in this Agreement, any Exhibit hereto or any document delivered in connection
herewith.

 

(c) “INDEMNIFIED
PERSONS” shall mean and include (A) with respect to an Indemnification Event described in subsections 5.1(b)(i) and 5.1(b)(iii)
hereof (each a “Seller Event of Indemnification”), the Buyer and its Affiliates, successors and assigns, and the officers,
directors and agents of the Buyer (the “Buyer Indemnified Persons”), or (B) with respect to an Indemnification Event
described in subsections 5.1(b)(iv) and 5.1(b)(v) hereof (each, a “Buyer Event of Indemnification”), the Seller and
their respective Affiliates, successors and assigns, and the respective officers, directors and agents of each of the foregoing
(the “Seller Indemnified Persons”).

 

(d) “INDEMNIFYING
PERSONS” shall mean and include (A) with respect to an Indemnification Event described in subsections 5.1(b)(i) and 5.1(b)(iii)
hereof, the Seller and their respective successors, assigns, heirs and legal representatives and estates, as the case may be (the
“Seller Indemnifying Persons”), and (B) with respect to an Indemnification Event described in subsections 5.1(b)(iv)
and 5.1(b)(v) hereof, the Buyer and its successors and assigns (the “Buyer Indemnifying Persons”).

 

(e) “LOSSES”
shall mean any and all losses, claims, damages, liabilities, expenses (including reasonable attorneys’, accountants’ and experts’
fees) sustained, suffered or incurred by any Indemnified Person arising from or in connection with any such matter that is the
subject of indemnification under Section 5.2 hereof that shall not exceed the amount of any consideration actually paid by such
Indemnifying Parties provided for hereunder.

 

5.2. INDEMNIFICATION
GENERALLY. Subject to Section 5.6 hereof, (a) the Seller Indemnifying Persons shall severally but not jointly indemnify the Buyer
Indemnified Persons for, and hold each of them harmless from and against, any and all Losses arising from or in connection with
any Seller Event of Indemnification, and (b) the Buyer Indemnifying Persons shall jointly and severally indemnify the Seller Indemnified
Persons for, and hold each of them harmless from and against, any and all Losses arising from or in connection with a Buyer Event
of Indemnification.

 

5.3. ASSERTION OF CLAIMS.
No claim shall be brought under Section 5.1 hereof unless the Indemnified Persons, or any of them, at any time prior to the applicable
Survival Date, give the Indemnifying Persons, as applicable, (a) written notice of the existence of any such claim, specifying
the nature and basis of such claim and the amount thereof, to the extent known, or (b) written notice pursuant to Section 5.4 of
any third party claim, the existence of which might give rise to such a claim but the failure so to provide such notice will not
relieve the Indemnifying Persons from any liability that they may have to the Indemnified Persons under this Agreement or otherwise
(unless and only to the extent that such failure results in the loss or compromise of any rights or defenses of the Indemnifying
Persons and they were not otherwise aware of such action or claim). Upon the giving of such written notice as aforesaid, the Indemnified
Persons, or any of them, shall have the right to commence legal proceedings prior or subsequent to the Survival Date for the enforcement
of their rights under Section 5.2 hereof.

 

    7 

     

    

 

5.4. NOTICE AND DEFENSE
OF THIRD PARTY CLAIMS. Losses resulting from the assertion of liability by third parties (each, a “Third Party Claim”)
shall be subject to the following terms and conditions:

 

(a) The Indemnified
Persons shall promptly give written notice to the Indemnifying Persons, as applicable, of any Third Party Claim that might give
rise to any Loss by the Indemnified Persons, or any of them, stating the nature and basis of such Third Party Claim, and the amount
thereof, to the extent known. Such notice shall be accompanied by copies of all relevant documentation with respect to such Third
Party Claim, including, without limitation, any summons, complaint or other pleading that may have been served, any written demand
or any other document or instrument. Notwithstanding the foregoing, the failure to provide notice as aforesaid will not relieve
the Indemnifying Persons from any liability which they may have to the Indemnified Persons under this Agreement or otherwise (unless
and only to the extent that such failure results in the loss or compromise of any rights or defenses of the Indemnifying Person
and they were not otherwise aware of such action or claim).

 

(b) If the
Indemnifying Person acknowledges in writing its obligation to indemnify the Indemnified Persons hereunder against any Losses that
may result from such Third Party Claims, then the Indemnifying Person shall be entitled, at its option, to assume and control the
defense of such Third Party Claim at its expense and through counsel of its reasonable choice if it gives notice to the Indemnified
Persons within twenty (20) calendar days of the receipt of notice of such Third Party Claim from the Indemnified Persons of its
intention to do so. If the Indemnifying Person elects to assume and control the defense of any such Third Party Claim, the Indemnified
Persons shall have the right to employ separate counsel and to participate in (but not control) the defense, compromise or settlement
of the Third Party Claim, but the fees and expenses of such counsel will be at the expense of the Indemnified Persons, unless (i)
the Indemnifying Person has agreed to pay such fees and expenses, or (ii) the Indemnified Persons has been advised by its counsel
that there may be one or more defenses reasonably available to it which are different from or additional to those available to
the Indemnifying Person, and in any such case that portion of the fees and expenses of such separate counsel that are reasonably
related to matters covered by the indemnification provided by this Article 5 will be paid by the Indemnifying Person. Expenses
of counsel to the Indemnified Persons shall be reimbursed on a current basis by the Indemnifying Person if there is no dispute
as to the obligation of the Indemnifying Person to pay such amounts pursuant to this Article 7. In the event the Indemnifying Person
exercises its right to undertake the defense against any such Third Party Claim as provided above, the Indemnified Persons shall
cooperate with the Indemnifying Person in such defense and make available to the Indemnifying Person, at the Indemnifying Person’s
expense, all witnesses, pertinent records, materials and information in its possession or under its control relating thereto as
is reasonably required by the Indemnifying Person. Similarly, in the event the Indemnified Persons is, directly or indirectly,
conducting the defense against any such Third Party Claim, the Indemnifying Person shall cooperate with the Indemnified Persons
in such defense and make available to it, at the Indemnifying Person’s expense, all such witnesses, records, materials and information
in its possession or under its control relating thereto as is reasonably required by the Indemnified Persons. No such Third Party
Claim, except the settlement thereof which involves the payment of money only (by a party or parties other than the Indemnified
Persons) and for which the Indemnified Persons is released by the third party claimant and is totally indemnified by the Indemnifying
Person, may be settled by the Indemnifying Person without the written consent of the Indemnified Persons. No Third Party Claim
which is being defended in good faith by the Indemnifying Person shall be settled by the Indemnified Persons without the written
consent of the Indemnifying Person.

 

5.5. SURVIVAL OF REPRESENTATIONS
AND WARRANTIES. Subject to the further provisions of this Section 5.5, the respective representations and warranties of all parties
shall survive the Closing Date until the applicable statute of limitation shall have expired (the “Survival Date”).

 

5.6. LIMITATION ON
INDEMNIFICATION.

 

(i)       Anything
to the contrary contained in this Article 5 notwithstanding, the Indemnifying Persons shall not be obligated to indemnify the
Indemnified Persons pursuant to this Article 5 with respect to any Losses pursuant to Section 5.2 until the aggregate amount of
such Losses exceeds fifty thousand dollars ($50,000) (the “Basket Amount”), whereupon the Indemnifying Persons shall
be obligated to indemnify the Indemnified Persons for all Losses in excess of the Basket Amount: 

 

    8 

     

    

 

(ii)       Each
Indemnifying Person’s liability for any Losses shall be limited to the amount of such Losses net of the difference between
any insurance proceeds received by the Indemnified Person in respect thereof minus the amount of premiums paid for such insurance
by the Indemnified Person.

 

5.7. RIGHT OF SET-OFF.
At its sole discretion and without limiting any other rights of the Buyer under this Agreement or at law or equity, the Buyer may
satisfy any Losses for which it is to be indemnified by the Seller in this Agreement in whole or in part by offset against any
funds, securities, or other property payable by the Buyer to the Seller and neither the exercise of nor the failure to exercise
such right of set-off will constitute an election of remedies or limit the Buyer in any manner in the enforcement of any other
remedies that may be available to them.

 

ARTICLE 6. 

MISCELLANEOUS 

 

6.1. EXPENSES. Each
party hereto shall bear its own fees and expenses in connection with the transactions contemplated hereby.

 

6.2. ENTIRE AGREEMENT.
This Agreement (including any Exhibits attached hereto), and the other writings referred to herein contain the entire agreement
among the parties hereto with respect to the transactions contemplated hereby and supersede all prior or contemporaneous agreements
or understandings, written or oral, among the parties with respect thereto.

 

6.3. DESCRIPTIVE HEADINGS.
Descriptive headings are for convenience only and shall not control or affect the meaning or construction of any provision of this
Agreement.

 

6.4. PUBLIC ANNOUNCEMENTS.
Seller acknowledges and agrees that the Buyer or Avalon may make public statements pertaining to this Agreement and the business
of the Buyer.

 

6.5. NOTICES. All notices
or other communications which are required or permitted hereunder shall be in writing and sufficient if delivered personally or
sent by nationally-recognized overnight courier or by registered or certified mail, postage prepaid, return receipt requested,
or by facsimile, with confirmation as provided above addressed as follows:

 

(a) if to
the Buyer, to:

 

Genexosome
Technologies Inc. 

83 South Street, Suite 101 

Freehold,
New Jersey 07728 

Attention:
Dr. David Jin, CEO

 

with a copy
(not constituting notice) to:

 

Fleming PLLC 

49 Front Street, Suite 206 

Rockville Centre, New York 11570 

Attention: Stephen M. Fleming 

Telecopier: (516) 977-1209

 

(b) if to
the Seller, to:

 

Yu Zhou 

________________________ 

________________________

 

(c) All such
notices or communications shall be deemed to be received (i) in the case of personal delivery or facsimile, on the date of such
delivery, (ii) in the case of nationally-recognized overnight courier, on the next Business Day after the date when sent and (iii)
in the case of mailing, on the third Business Day following the date on which the piece of mail containing such communication was
posted.

 

    9 

     

    

 

6.6. COUNTERPARTS.
This Agreement may be executed in any number of counterparts by original or facsimile signature, each such counterpart shall be
an original instrument, and all such counterparts together shall constitute one and the same agreement.

 

6.7. GOVERNING LAW.
This Agreement shall be governed by and construed in accordance with the laws of the State of New Jersey applicable to contracts
made and to be performed wholly therein (without regard to principles of conflicts of laws).

 

6.8. BENEFITS OF AGREEMENT.
All the terms and provisions of this Agreement shall be binding upon and inure to the benefit of the parties hereto and their respective
successors and permitted assigns.

 

6.9. PRONOUNS. As used
herein, all pronouns shall include the masculine, feminine, neuter, singular and plural thereof whenever the context and facts
require such construction.

 

6.10. AMENDMENT, MODIFICATION
AND WAIVER. This Agreement shall not be altered or otherwise amended except pursuant to an instrument in writing signed by (i)
the Buyer and (ii) the Seller; provided, however, that any party to this Agreement may waive any obligation owed to it by any other
party under this Agreement. The waiver by any party hereto of a breach of any provision of this Agreement shall not operate or
be construed as a waiver of any subsequent breach.

 

6.11. SEVERABILITY.
If any term or other provision of this Agreement is invalid, illegal or incapable of being enforced by any rule of law or public
policy, all other conditions and provisions of this Agreement shall nevertheless remain in full force and effect so long as the
economic or legal substance of the transactions contemplated hereby is not affected in any manner adverse to any party. Upon such
determination that any term or other provision is invalid, illegal or incapable of being enforced, the parties hereto shall negotiate
in good faith to modify this Agreement so as to effect the original intent of the parties as closely as possible in an acceptable
manner to the end that the transactions contemplated hereby are fulfilled to the greatest extent possible.

 

6.12. FURTHER ASSURANCES.
Each party agrees to cooperate fully with the other parties and to execute such further instruments, documents and agreements and
to give such further written assurances as may be reasonably requested by any other party to evidence and reflect the transactions
described herein and contemplated hereby and to carry into effect the intents and purposes of this Agreement.

 

6.13. CONSENT TO JURISDICTION;
WAIVERS. Any action brought by either party against the other concerning the transactions contemplated by this Agreement shall
be brought only in the state courts of New Jersey or in the federal courts located in the state and county of Monmouth. Each of
the parties hereto further agrees that service of any process, summons, notice or document by U.S. registered mail to such party’s
respective address set forth in Section 6.5 shall be effective service of process for any Action in New Jersey with respect to
any matters to which it has submitted to jurisdiction in this Section 6.13. For purposes of this Agreement, “Action”
means any claim, action, suit or arbitration, or any other proceeding, in each instance by or before any Governmental Authority
or any nongovernmental arbitration, mediation or other nonjudicial dispute resolution body.

 

6.14. WAIVER OF JURY
TRIAL. Each of the parties hereto irrevocably and unconditionally waives trial by jury in any Action relating to this Agreement
or any transaction contemplated hereby or thereby, and for any counterclaim with respect thereto.

 

[REMAINDER OF PAGE INTENTIONALLY LEFT
BLANK]

 

    10 

     

    

 

IN WITNESS WHEREOF, each of the parties hereto has caused this
Asset Purchase Agreement to be executed on its behalf as of the day and year first above written.

 

	 	GENEXOSOME TECHNOLOGIES INC.	 
	 	 	 
	 	By: /s/ Dr. David Jin	 
	 	Name: Dr. David Jin	 
	 	Title: Chief Executive Officer	 
	 	 	 
	 	/s/ Yu Zhou	 
	 	 	 
	 	Yu Zhou	 

 

    11 

     

    

 

SCHEDULES

 

Schedule 1.1(a)

 

Patents

 

	CURRENT OWNED INTELLECTUAL PROPERTY  in China (to be filed in USA)
	Application of an Exosomal MicroRNA in plasma as biomaker to diagnosis LIVER CANCER 	
        Patent application number: 

        CN 2016 1 0675107.5 

	Clinical application of circulating exosome carried miRNA-33b in the diagnosis of liver cancer	
        Patent application number: 

        CN 2016 1 0675110.7 

	Saliva Exosome based methods and composition for the Diagnosis, Staging and Prognosis of ORAL CANCER	
        Patent application number: 

        CN 2017 1 0330847.X 

	A novel exosome-based therapeutics against proliferative oral diseases	
        Patent application number: 

        CN 2017 1 0330835.7 

 

 

    12Exhibit 10.3

 

STOCK PURCHASE AGREEMENT

 

This Stock Purchase Agreement
(“Agreement”) is made and entered into as of this 25th day of October, 2017, by and among Genexosome Technologies Inc.,
a Nevada corporation having its principal offices at 83 South Street, Suite 101, Freehold, NJ 07728 (the “Purchaser”),
Yu Zhou who resides at 6968 Ernest Way, Dublin, Ohio 43017 (hereinafter, the “Seller”), and BEIJING JIETENG (GENEXOSOME)
BIOTECH CO., LTD., a corporation organized in the Peoples Republic of China having its principal offices at Room 101, Building
4, Chaoqian Road, Changping District, Beijing (the “Company”).

 

W I T N E S S E T H :

 

WHEREAS, the Company
is engaged in researching, developing and commercializing exosome technologies (hereinafter the “Business”), and the
Seller is the owner of all of the Company’s issued and outstanding capital stock; and

 

WHEREAS, the Purchaser
is also engaged in the Business and desires to acquire the Company and the Business and the Seller wishes to sell the Company and
the Business;

 

NOW, THEREFORE,
in consideration of the premises, the mutual representations, warranties, covenants and agreements hereinafter contained, and other
good and valuable consideration the receipt and sufficiency of which are hereby acknowledged, and intending to be legally bound,
the parties agree as follows:

 

1.       SALE
OF SHARES. Subject to and upon the terms and conditions hereinafter set forth and the representations and warranties contained
herein, at the Closing (the “Closing”) on the Closing Date (as defined in Section 7 below), Seller agrees to
sell, assign, transfer and deliver to Purchaser, free and clear of all liens, claims, and encumbrances thereon, and the Purchaser
agrees to purchase from Seller, all of the issued and outstanding shares of capital stock of the Company (the “Shares”).
Yu Zhou owns 100% of the Shares.

 

2.       PRICE
AND CONSIDERATION. The purchase price to be paid by Purchaser for the Shares is Four Hundred Fifty Thousand and No/100
Dollars ($450,000.00), which shall be paid upon the Company recording the change in ownership with the Ministry of Commerce of
the People’s Republic of China in accordance with the Interim Measures for Record Management regarding the Establishment
and Change of Foreign-invested Enterprises (revised) (the “Ministry Change”).

 

3.       REPRESENTATIONS
AND WARRANTIES. Each Seller and the Company, jointly and severally, make the following representations and warranties to
the Purchaser as an inducement for it to enter into this Agreement. For purposes of this Agreement, where a representation or warranty
is limited by the knowledge of Seller or the Company, the Seller and the Company shall be regarded as having the actual knowledge
of Yu Zhou and the knowledge such person should have after the due and diligent inquiry of a prudent person.

 

    Page 1 

     

    

 

3.01.       Organization
and Good Standing of the Company. The Company is a corporation duly organized, validly existing and in good standing under
the laws of the Peoples Republic of China. The Company is not required to be qualified to transact business in any other jurisdiction
where the failure to so qualify would have an adverse effect on the business of the Company.

 

3.02.       Authority.

 

(a)       The
Company has full power and authority (corporate and otherwise) to carry on its business and has all permits and licenses that are
necessary to the conduct of its business or to the ownership, lease or operation of its properties and assets.

 

(b)       The
execution of this Agreement and the delivery hereof to the Purchaser and the sale contemplated herein have been, or will be prior
to Closing, duly authorized by the Company’s Board of Directors and by the Company’s stockholders having full power
and authority to authorize such actions.

 

(c)       The
Seller and the Company have the full legal right, power and authority to execute, deliver and carry out the terms and provisions
of this Agreement; and this Agreement has been duly and validly executed and delivered on behalf of Seller and the Company and
constitutes a valid and binding obligation of each Seller and the Company enforceable in accordance with its terms.

 

(d)       Neither
the execution and delivery of this Agreement, the consummation of the transactions herein contemplated, nor compliance with the
terms of this Agreement will violate, conflict with, result in a breach of, or constitute a default under any statute, regulation,
indenture, mortgage, loan agreement, or other agreement or instrument to which the Company or any Seller is a party or by which
it or any of them is bound, any charter, regulation, or bylaw provision of the Company, or any decree, order, or rule of any court
or governmental authority or arbitrator that is binding on the Company or any Seller in any way.

 

3.03.       Shares.

 

(a)       The
Company’s authorized capital stock consists of _____ shares of Common Stock, par value $____ per share, of which ____ shares
have been issued to Seller and constitute the Shares as defined above. All of the Shares are duly authorized, validly issued, fully
paid and non-assessable.

 

(b)       The
Seller is the lawful record and beneficial owners of all the Shares, free and clear of any liens, pledges, encumbrances, charges,
claims or restrictions of any kind, e and have, or will have on the Closing Date, the absolute, unilateral right, power, authority
and capacity to enter into and perform this Agreement without any other or further authorization, action or proceeding, except
as specified herein.

 

    Page 2 

     

    

 

(c)       There
are no authorized or outstanding subscriptions, options, warrants, calls, contracts, demands, commitments, convertible securities
or other agreements or arrangements of any character or nature whatever under which any Seller or the Company are or may become
obligated to issue, assign or transfer any shares of capital stock of the Company. Upon the delivery to Purchaser on the Closing
Date of the certificate(s) representing the Shares, Purchaser will have good, legal, valid, marketable and indefeasible title to
all the then issued and outstanding shares of capital stock of the Company, free and clear of any liens, pledges, encumbrances,
charges, agreements, options, claims or other arrangements or restrictions of any kind.

 

3.04.       Basic
Corporate Records. The copies of the Articles of Incorporation of the Company and the Bylaws of the Company all of which have
been delivered to the Purchaser, are true, correct and complete as of the date of this Agreement.

 

3.05.       Minute
Books. The minute books of the Company, which shall be exhibited to the Purchaser between the date hereof and the Closing Date,
each contain true, correct and complete minutes and records of all meetings, proceedings and other actions of the shareholders,
Boards of Directors and committees of such Boards of Directors of each such corporation, if any, and, on the Closing Date, will
contain true, correct and complete minutes and records of any meetings, proceedings and other actions of the shareholders, respective
Boards of Directors and committees of such Boards of Directors of each such corporation.

 

3.06.       Subsidiaries
and Affiliates. The Company does not own any subsidiaries.

 

3.07.       Consents.
No consents or approvals of any public body or authority and no consents or waivers from other parties to leases, licenses, franchises,
permits, indentures, agreements or other instruments are (i) required for the lawful consummation of the transactions contemplated
hereby, or (ii) necessary in order that the Business can be conducted by the Purchaser in the same manner after the Closing as
heretofore conducted by the Company, nor will the consummation of the transactions contemplated hereby result in creating, accelerating
or increasing any liability of the Company.

 

3.08.       Financial
Statements. The Seller has delivered, or will deliver prior to Closing, to the Purchaser copies of the following financial
statements (which include all notes and schedules attached thereto), all of which are true, complete and correct, have been prepared
from the books and records of the Company in accordance with generally accepted accounting principles consistently applied with
past practice and fairly present the financial condition, assets, liabilities and results of operations of the Company as of the
dates thereof and for the periods covered thereby:

 

(i)           Audited
Balance Sheets of the Company for each of the two (2) years ending December 31, 2016 and 2015, and the related Statements of Operations
and Retained Earnings and Statements of Cash Flows of the Company for the fiscal years then ended (the “Financial Statements”);
and

 

    Page 3 

     

    

 

(ii)          Reviewed
Balance Sheets of the Company as of June 30, 2017 and 2016 and the related Statements of Operations, Retained Earnings and Cash
Flows for the six and three months ended June 30, 2016 and 2015. (collectively, the “Interim Financial Statements”).

 

In such financial statements,
the Statements of Operations do not contain any items of special or nonrecurring income or any other income not earned in the ordinary
course of business except as expressly specified therein, and the financial statements for the interim periods indicated include
all adjustments, which consist of only normal recurring accruals, necessary for such fair presentation. The independent registered
public accounting firm’s reports do not contain a qualified opinion. There are no facts known to the Seller or the Company
that, under generally accepted accounting principles consistently applied, would alter the information contained in the foregoing
financial statements in any material way.

 

3.09.       Records
and Books of Account. The records and books of account of the Company reflect all material items of income and expense and
all material assets, liabilities and accruals, and have been, and to the Closing Date will be, regularly kept and maintained in
conformity with generally accepted accounting principles applied on a consistent basis with preceding years.

 

3.10.       Absence
of Undisclosed Liabilities. Except as and to the extent reflected or reserved against in the Company’s Reviewed Balance
Sheet as of June 30, 2017 (hereinafter the “Basic Warranty Date Balance Sheet” and the “Basic Warranty Date”,
respectively) there are no liabilities or obligations of the Company of any kind whatsoever.

 

		3.11.	Taxes.

 

(a)       For
purposes of this Agreement, “Tax” or “Taxes” refers to: (i) any and all federal, state, local and foreign
taxes, assessments and other governmental charges, duties, impositions and liabilities relating to taxes, including taxes based
upon or measured by gross receipts, income, profits, sales, use and occupation, and value added, ad valorem, transfer, franchise,
withholding, payroll, recapture, employment, excise and property taxes and escheatment payments, together with all interest, penalties
and additions imposed with respect to such amounts and any obligations under any agreements or arrangements with any other person
with respect to such amounts and including any liability for taxes of a predecessor entity; (ii) any liability for the payment
of any amounts of the type described in clause (i) as a result of being or ceasing to be a member of an affiliated, consolidated,
combined or unitary group for any period (including, without limitation, any liability under Treas. Reg. Section 1.1502-6 or any
comparable provision of foreign, state or local law); and (iii) any liability for the payment of any amounts of the type described
in clause (i) or (ii) as a result of any express or implied obligation to indemnify any other person or as a result of any obligations
under any agreements or arrangements with any other person with respect to such amounts and including any liability for taxes of
a predecessor entity.

 

    Page 4 

     

    

 

 (b)      (i)           The Company has timely filed
all federal, state, local and foreign returns, estimates, information statements and reports (“Returns”) relating to
Taxes required to be filed by the Company with any Tax authority. All such Returns are true, correct and complete in all respects.
The Company has paid all Taxes shown to be due on such Returns.

 

(ii)          The
Company, as of the Closing Date, will have withheld and accrued or paid to the proper authority all Taxes required to have been
withheld and accrued or paid.

 

(iii)         The
Company has not been delinquent in the payment of any Tax nor is there any Tax deficiency outstanding or assessed against the Company.
The Company has not executed any unexpired waiver of any statute of limitations on or extending the period for the assessment or
collection of any Tax.

 

(iv)         There
is no dispute, claim, or proposed adjustment concerning any Tax liability of the Company either (A) claimed or raised by any Tax
authority in writing or (B) based upon personal contact with any agent of such Tax authority, and there is no claim for assessment,
deficiency, or collection of Taxes, or proposed assessment, deficiency or collection from the Internal Revenue Service or any other
governmental authority against the Company which has not been satisfied.

 

3.12.       Patents,
Software, Trademarks, Etc. The Company owns, or possesses adequate licenses or other rights to use, all patents, software,
trademarks, service marks, trade names and copyrights and trade secrets, if any, necessary to conduct its business as now operated
by it.

 

4.            REPRESENTATIONS
AND WARRANTIES OF PURCHASER. The Purchaser makes the following representations and warranties to the Seller and the Company.

 

4.01.       Organization.
The Purchaser is a corporation duly organized, validly existing and in good standing under the laws of the State of Nevada. The
Purchaser has the corporate power to own its properties, to carry on its business as now being conducted, and to enter into and
perform the terms and provisions of this Agreement.

 

4.02.       Authorization.
The execution and delivery of this Agreement and the consummation of the transactions contemplated herein have been, or will prior
to Closing be, duly and validly approved and acknowledged by all necessary corporate action on the part of the Purchaser.

 

4.03.       No
Conflict or Violation. The execution and delivery of this Agreement, the acquisition of the Shares by Purchaser and the consummation
of the transactions herein contemplated, and the compliance with the provisions and terms of this Agreement, are not prohibited
by the Articles of Incorporation or Bylaws of the Purchaser and will not violate, conflict with or result in a breach of any of
the terms or provisions of, or constitute a default under, any court order, indenture, mortgage, loan agreement, or other agreement
or instrument to which the Purchaser is a party or by which it is bound.

 

    Page 5 

     

    

 

4.04.       Investment
Representation. The Shares are being purchased by the Purchaser solely for investment and not for the purpose of resale to
any third party.

 

5.           PURCHASER’S
CONDITIONS OF CLOSING. All obligations of the Purchaser hereunder are subject, at the option of the Purchaser, to the fulfillment
prior to or at Closing of each of the following conditions:

 

5.01.       Discovery
of Adverse Error, Misstatement or Omission. The Purchaser shall not have discovered any material adverse error, misstatement
or omission in information relating to the Company included either herein or in any certificate or document delivered to Purchaser
pursuant hereto or in connection with the transactions contemplated hereby including, without limitation, any material adverse
error, misstatement or omission in the representations and warranties made by the Seller or the Company in or pursuant to this
Agreement.

 

5.02.       Representations
at Time of Closing. The representations and warranties of the Seller and the Company contained in this Agreement (including
the Schedules and Exhibits hereto) and in any certificate or documents delivered to the Purchaser pursuant hereto shall be deemed
to have been made again at and as of the time of Closing with dates therein updated to the Closing Date and, as so updated and
made, shall then be true, complete and correct, except for changes in the ordinary course of business not materially adversely
affecting the business, properties or financial condition of the Company, or changes required by or contemplated by this Agreement.

 

5.03.       Performance
of Agreements. The Seller and the Company shall have performed and complied with all agreements and conditions required by
this Agreement to be performed or complied with by them prior to or at Closing.

 

5.04.       Adverse
Change. During the period from the Basic Warranty Date to the Closing Date there shall not have been any material adverse change
in the financial condition, assets, liabilities or business of the Company (a “Material Adverse Change”).

 

5.05.       Consents,
Approvals and Waivers. The Seller and the Company shall have obtained any and all consents and approvals to the transfer or
assignment to the Purchaser of all of the Shares of the Company that may be necessary to avoid any breach of, default by, or acceleration
of obligations of the Company under any agreement or instrument by reason of such transfer and assignment, and any waivers by any
parties to such agreements necessary to avoid any such breaches, defaults or accelerations. In addition, the Seller and the Company
shall have obtained all consents, authorizations, approvals and orders of governmental authorities required in connection with
the consummation of the transactions contemplated by this Agreement and necessary in order that the Business can be conducted in
all respects after the Closing as it has been conducted prior to the Closing.

 

    Page 6 

     

    

 

5.06.       Orders,
Etc. There shall not be in effect any order, injunction, ruling or decree, whether or not appealable, issued by any court or
administrative agency of competent jurisdiction, that prohibits the consummation of the transactions contemplated by this Agreement,
or that impairs materially the ability of Purchaser to realize the benefits of such transactions. If any such order, injunction,
ruling or decree is in effect on the Closing Date, the Closing Date, at the option of Purchaser, will be extended for as long as
such order, injunction, ruling or decree requires; in such event, the parties shall each use their commercially reasonable best
efforts to cause such order, injunction, ruling or decree to be modified, overruled, vacated or otherwise changed so as to permit
the Closing to be consummated as soon as possible.

 

5.07.       Pending
or Threatened Litigation. There shall not be pending nor shall there be threatened any legal proceeding commenced by any governmental
body, or any other person or entity, in which there is sought any order, injunction, ruling or decree by a court or administrative
agency of competent jurisdiction, that would prohibit the consummation of the transactions contemplated by this Agreement, or that
would impair materially the ability of Purchaser to realize the benefits of such transaction.

 

6.           SELLER’S
CONDITIONS OF CLOSING. All obligations of the Seller and the Company under this Agreement are subject to the condition
that:

 

6.01.       Representations
at Time of Closing. The Purchaser’s representations and warranties contained in this Agreement shall be deemed to have
been made again at and as of the time of the Closing and shall then be true in all material respects.

 

6.02.       Discovery
of Misrepresentations. The Seller and the Company shall not have discovered any material adverse error, misstatement or omission
in the representations and warranties made by the Purchaser herein, and all the terms, covenants and conditions of this Agreement
to be complied with and performed by the Purchaser on or before the Closing Date shall have been complied with and performed.

 

7.          CLOSING.
Subject to satisfaction of the conditions precedent contained in Article 5 and Article 6, and on the other terms and conditions
herein contained, the transactions provided for herein shall be consummated at the Closing to be held at a location mutually agreeable
to the parties in Freehold, New Jersey, on or about October 20, 2017 or at such other time, date and place as the parties may
agree upon in writing (such date of Closing herein being the “Closing Date”).

 

    Page 7 

     

    

 

8.           EXCHANGE
OF CONSIDERATION. In reliance on the representations and warranties contained herein, and subject to the terms and conditions
of this Agreement, the following exchanges shall take place at Closing, each of which is both an affirmative obligation of the
party specified for making the exchange and a condition to Closing that may be asserted or waived by the party specified for receiving
the exchange:

 

8.01.       Cash
to Seller. Within ten (10) days of the Ministry Change, Purchaser will deliver to Seller by certified or bank check or by wire
transfer the sum of Four Hundred Fifty Thousand and No/100 Dollars ($450,000.00).

 

9.           NOTICES.
All notices, requests, demands and other communications hereunder shall be in writing and shall be deemed to have been duly given
if delivered personally or to a national courier service, or mailed by registered or certified mail, return receipt requested,
to the addresses herein designated or at such other address as may be designated in writing by notice given personally or by national
courier service or by registered or certified mail return receipt requested:

 

If to the Seller (or the Company
up to the Closing), to:

 

Yu Zhou

6968 Ernest Way

Dublin, Ohio 43017

 

If to Purchaser or the Company
after the Closing, to:

 

Genexosome Technologies
Inc.

83 South Street, Suite 101

Freehold, New Jersey
07728

Attention: Dr. David
Jin, CEO

 

with a copy (not constituting
notice) to:

 

Fleming PLLC

49 Front Street, Suite 206

Rockville Centre, New York 11570

Attention: Stephen M. Fleming

Telecopier: (516) 977-1209

 

10.       GOVERNING
LAW. The Agreement shall be governed by and construed in accordance with the laws of the State of New Jersey.

 

11.       ENTIRE
AGREEMENT. This instrument, together with the Schedules and Exhibits hereto and the financial statements referred to herein,
contains the entire Agreement between the parties hereto with respect to the transactions contemplated herein and supersedes all
previous written or oral negotiations, commitments and representations.

 

    Page 8 

     

    

 

12.       AMENDMENTS.
This Agreement may be changed or modified only by an instrument executed by the Seller and by the Company and the Purchaser acting
by their respective officers thereunto duly authorized by their respective Boards of Directors.

 

13.       SECTION
AND OTHER HEADINGS. The section and other headings contained in this Agreement are for reference purposes only and do not
affect the interpretation or meaning of this Agreement.

 

14.       COUNTERPARTS.
This Agreement may be executed in one or more counterparts, each of which shall be deemed an original, but all of which together
shall constitute one and the same Agreement.

 

[REMAINDER OF PAGE LEFT BLANK

SIGNATURE PAGE TO FOLLOW]

 

    Page 9 

     

    

 

IN WITNESS WHEREOF,
the parties hereto have caused this Agreement to be duly executed as of the day and year first above written.

 

	PURCHASER	 	THE COMPANY
	 	 	 
	Genexosome Technologies Inc.	 	Beijing Jieteng (Genexosome) Biotech Co. Ltd.
	 	 	 
	By: /s/ Dr. David Jin	 	By: /s/ Yu Zhou
	Name: Dr. David Jin	 	Name: Yu Zhou
	Title: CEO	 	Title: CEO
	 	 	 
	 	 	/s/Yu Zhou
	 	 	Yu Zhou, Seller

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00275-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00275-of-00352.parquet"}]]